Ibuprofen

Generic Name
Ibuprofen
Brand Names
Addaprin, Advil, Advil Cold and Sinus, Advil Congestion Relief, Advil PM, Advil Sinus Congestion and Pain, Alivio, Caldolor, Cedaprin, Children's Ibuprofen, Diphen, Duexis, Ibu, Ibutab, Junior Strength Motrin, Motrin, Motrin PM, Neoprofen, Nuprin, Pedea, Proprinal, Reprexain, Sudafed PE Head Congestion Plus Pain, Vicoprofen, Wal-profen Congestion Relief and Pain, Ibuprofen Gen.Orph
Drug Type
Small Molecule
Chemical Formula
C13H18O2
CAS Number
15687-27-1
Unique Ingredient Identifier
WK2XYI10QM
Background

Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) derived from propionic acid and it is considered the first of the propionics. The formula of ibuprofen is 2-(4-isobutylphenyl) propionic acid and its initial development was in 1960 while researching for a safer alternative for aspirin. Ibuprofen was finally patented in 1961 and this drug was first launched against rheumatoid arthritis in the UK in 1969 and USA in 1974. It was the first available over-the-counter NSAID.

On the available products, ibuprofen is administered as a racemic mixture. Once administered, the R-enantiomer undergoes extensive interconversion to the S-enantiomer in vivo by the activity of the alpha-methylacyl-CoA racemase. In particular, it is generally proposed that the S-enantiomer is capable of eliciting stronger pharmacological activity than the R-enantiomer.

Indication

Ibuprofen is the most commonly used and prescribed NSAID. It is a very common over-the-counter medication widely used as an analgesic, anti-inflammatory and antipyretic.

The use of ibuprofen and its enantiomer Dexibuprofen in a racemic mix is common for the management of mild to moderate pain related to dysmenorrhea, headache, migraine, postoperative dental pain, spondylitis, osteoarthritis, rheumatoid arthritis, and soft tissue disorder.

Due to its activity against prostaglandin and thromboxane synthesis, ibuprofen has been attributed to alteration of platelet function and prolongation of gestation and labour.

As ibuprofen is a widely used medication, the main therapeutic indications are:

Associated Conditions
Acute Pain, Ankylosing Spondylitis (AS), Common Cold, Cystic Fibrosis (CF), Fever, Gastric Ulcer, Gout, Headache, Insomnia, Juvenile Idiopathic Arthritis (JIA), Menstrual Distress (Dysmenorrhea), Migraine, Mild pain, Nasal Congestion, Osteoarthritis (OA), Pain, Pain, Inflammatory, Patent Ductus Arteriosus (PDA), Pericarditis, Primary Dysmenorrhoea, Rheumatoid Arthritis, Severe Pain, Sinus pressure, Mild to moderate pain, Minor aches and pains, Moderate Pain
Associated Therapies
-

Study Evaluating The Efficacy Of A Novel Ibuprofen Formulation On Fever In Patients With An Uncomplicated Acute Infection

Phase 3
Terminated
Conditions
Interventions
First Posted Date
2009-12-18
Last Posted Date
2012-08-21
Lead Sponsor
Pfizer
Target Recruit Count
16
Registration Number
NCT01035346
Locations
🇺🇸

Pfizer Investigational Site, Salt Lake City, Utah, United States

Placebo and Active Controlled, Double Dummy Study to Prove Efficacy of Aspirin in Treatment of Acute Low Back Pain

First Posted Date
2009-12-09
Last Posted Date
2009-12-09
Lead Sponsor
Bayer
Target Recruit Count
338
Registration Number
NCT01028079

Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients

Phase 3
Completed
Conditions
Interventions
First Posted Date
2009-10-27
Last Posted Date
2016-11-06
Lead Sponsor
Cumberland Pharmaceuticals
Target Recruit Count
118
Registration Number
NCT01002573
Locations
🇺🇸

Staten Island University Hospital, Staten Island, New York, United States

🇺🇸

Texas Children's Hospital, Houston, Texas, United States

🇺🇸

Children's Memorial Hermann Hospital, Houston, Texas, United States

and more 14 locations

Efficacy Study of Prophylactic Ibuprofen Versus Placebo on Pain Relief and Success Rates of Medical Abortion

Phase 3
Completed
Conditions
Interventions
First Posted Date
2009-10-16
Last Posted Date
2012-02-17
Lead Sponsor
Sheba Medical Center
Target Recruit Count
61
Registration Number
NCT00997074
Locations
🇮🇱

Sheba Medical Center, Tel Aviv, Israel

To Evaluate the Safety, Tolerability and Analgesic Efficacy of SAF312 in Postoperative Dental Pain Patients

First Posted Date
2009-09-30
Last Posted Date
2020-12-19
Lead Sponsor
Novartis
Target Recruit Count
183
Registration Number
NCT00986882
Locations
🇺🇸

Jean Brown Research, Salt Lake City, Utah, United States

Effects of ICA-105665 Using the Intradermal Capsaicin and Ultraviolet B (UV-B) Models in Healthy Male Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-08-20
Last Posted Date
2012-09-28
Lead Sponsor
Pfizer
Target Recruit Count
25
Registration Number
NCT00962663
Locations

Pfizer Investigational Site

Ibuprofen as a Possible Preventer of Post Bronchoscopy Fever

Phase 2
Completed
Conditions
Interventions
First Posted Date
2009-08-07
Last Posted Date
2020-10-26
Lead Sponsor
Shaare Zedek Medical Center
Target Recruit Count
64
Registration Number
NCT00954200
Locations
🇮🇱

Shaare Zedek Medical Center POB 3235, Jerusalem, Israel

🇮🇱

Shaare Zedek Medical Center, Jerusalem, Israel

A Comparison Study of Pain Relief From Dysmenorrhea Between the Vipon Tampon and Ibuprofen

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2009-08-04
Last Posted Date
2011-06-16
Lead Sponsor
Another Way Products
Target Recruit Count
115
Registration Number
NCT00951561
Locations
🇺🇸

University of Kansas Medical Center, Department of Obstetrics and Gynecology, Kansas City, Missouri, United States

🇺🇸

Truman Medical Center, Kansas City, Missouri, United States

Single Dose Study of N1539 in the Treatment of Pain Secondary to Dental Impaction Surgery

Phase 2
Completed
Conditions
Interventions
First Posted Date
2009-07-24
Last Posted Date
2011-12-02
Lead Sponsor
Alkermes, Inc.
Target Recruit Count
230
Registration Number
NCT00945763
Locations
🇺🇸

Jean Brown Research, Salt Lake City, Utah, United States

Pharmacokinetics of 3 Formulations of Ibuprofen Suppositories

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-06-16
Last Posted Date
2011-10-06
Lead Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Target Recruit Count
25
Registration Number
NCT00921830
Locations
🇮🇪

Shandon Clinic, Cork, Co. Cork, Ireland

© Copyright 2024. All Rights Reserved by MedPath